About Spirosure
Spirosure is a company based in Pleasanton (United States) founded in 2011 by Solomon Ssenyange was acquired by CAIRE in June 2020.. Spirosure has raised $50 million across 4 funding rounds from investors including Fosun Pharmaceutical, Caireinc and Niterra Ventures. The company has 12 employees as of December 31, 2022. Spirosure operates in a competitive market with competitors including Eversens, Linshom, Apieron, Deep Breath Intelligence and Deversify, among others.
- Headquarter Pleasanton, United States
- Employees 12 as on 31 Dec, 2022
- Founders Solomon Ssenyange
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spirosure, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 M (USD)
in 4 rounds
-
Latest Funding Round
$15 M (USD), Series C
Jan 08, 2018
-
Investors
Fosun Pharmaceutical
& 7 more
-
Employee Count
12
as on Dec 31, 2022
-
Acquired by
CAIRE
(Jun 03, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Spirosure
Spirosure has successfully raised a total of $50M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $15 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $15.0M
-
First Round
First Round
(30 Oct 2014)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series C - Spirosure | Valuation |
investors |
|
| Jun, 2016 | Amount | Series C - Spirosure | Valuation |
investors |
|
| Nov, 2014 | Amount | Series B - Spirosure | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spirosure
Spirosure has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Fosun Pharmaceutical, Caireinc and Niterra Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative ideas are transformed into reality by Niterra Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage sector-agnostic VC firm investing in geographies such as the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spirosure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spirosure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spirosure Comparisons
Competitors of Spirosure
Spirosure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eversens, Linshom, Apieron, Deep Breath Intelligence and Deversify, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of non-invasive diagnostic system to detect bio-markers
|
|
| domain | founded_year | HQ Location |
Developer of respiratory monitoring devices
|
|
| domain | founded_year | HQ Location |
Functions as an asthma monitoring device for health management.
|
|
| domain | founded_year | HQ Location |
AI and mass spectrometry platforms for personalized medicine are developed.
|
|
| domain | founded_year | HQ Location |
Breath analyzers for acetone concentration in exhaled air are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive respiratory measurement devices are developed for gas exchange assessment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spirosure
Frequently Asked Questions about Spirosure
When was Spirosure founded?
Spirosure was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Spirosure located?
Spirosure is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Is Spirosure a funded company?
Spirosure is a funded company, having raised a total of $50M across 4 funding rounds to date. The company's 1st funding round was a Series B of $8.6M, raised on Oct 30, 2014.
How many employees does Spirosure have?
As of Dec 31, 2022, the latest employee count at Spirosure is 12.
What does Spirosure do?
Spirosure is engaged in the research, development and commercialization of novel breath analysis devices for the diagnosis and management of diseases. The companys current focus is on the non-invasive monitoring and management of chronic pulmonary diseases such as Asthma, COPD, cystic fibrosis, and pulmonary hypertension. Their products include the Fenom PRO POC breathalyzer and the Fenom HOME at-home breathalyzer for measurement of fractional exhaled Nitric Oxide in the management of Asthma.
Who are the top competitors of Spirosure?
Who are Spirosure's investors?
Spirosure has 8 investors. Key investors include Fosun Pharmaceutical, Caireinc, Niterra Ventures, NGK Spark Plugs, and South Valley Angels.